MedPharm Wins Category at 2019 CPhI Pharma Awards
The company announced it was named the winner of the Analysis, Testing, and Quality Control category.
MedPharm, a UK-based contract provider of topical and transdermal product design and formulation development services, announced it was named the winner of the Analysis, Testing, and Quality Control category at the 2019 CPhI Pharma Awards on Nov. 5, 2019.
According to a company press release, MedPharm attributes the win to its dedication to discovering new ways to demonstrate the bioequivalence of topical generic products in regulatory submissions. This includes working with regulatory authorities to develop in-vitro models and statistical justification using multiple donors.
“This award is a testament to MedPharm’s depth of experience and integrity in the field of in vitro modeling and topical formulation development,” said Eugene Ciolfi, president and CEO of MedPharm, in the press release. “By refining and automating these in-vitro models MedPharm has created a cost-effective route to demonstrating bioequivalence.”
Source: MedPharm
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
